A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting
NCT05059600 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52
Last updated 2025-09-15
Summary
The primary purpose of this study was to evaluate whether the safe-use conditions for administration of brexanolone (ZULRESSO®) can be implemented in a home setting.
Conditions
Interventions
- DRUG
-
ZULRESSO®
Intravenous infusion of ZULRESSO®.
Sponsors & Collaborators
-
Supernus Pharmaceuticals, Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-08
- Primary Completion
- 2022-07-14
- Completion
- 2022-07-14
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Preventing Postpartum Depression With Intranasal Oxytocin
NCT02505984 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression
NCT02235064 ·Status: TERMINATED ·Phase: NA
-
A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression
NCT03228394 ·Status: COMPLETED ·Phase: PHASE2
-
PRogram In Support of Moms: An Innovative Stepped-Care Approach for Obstetrics and Gynecology Clinics
NCT02760004 ·Status: COMPLETED ·Phase: NA
-
Progesterone & Postpartum Relapse to Smoking
NCT01798394 ·Status: COMPLETED ·Phase: NA
-
Progesterone for Postpartum Cocaine Relapse
NCT01249274 ·Status: COMPLETED ·Phase: NA
-
Sertraline for the Prevention of Recurrent Postpartum Depression
NCT00276900 ·Status: COMPLETED ·Phase: PHASE3
-
Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications
NCT01796132 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression
NCT04011592 ·Status: TERMINATED ·Phase: PHASE2
-
Night Respite for Postpartum Mothers With SUD
NCT05746507 ·Status: COMPLETED ·Phase: NA
-
Prevention of Postpartum Depression in Low-Income Women
NCT00053651 ·Status: COMPLETED ·Phase: PHASE1
-
Interpersonal Psychotherapy for Maternal Depression
NCT02310529 ·Status: COMPLETED ·Phase: NA
-
A Phase II Study of HS-10353 in Participants With Postpartum Depression
NCT05937867 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression
NCT02614547 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Hormones in Postpartum Mood Disorders
NCT00001481 ·Status: COMPLETED ·Phase: PHASE2
-
Emotional and Cardiac Impact of Postpartum Haemorrhage
NCT02118038 ·Status: COMPLETED
-
A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
NCT03460756 ·Status: COMPLETED ·Phase: PHASE2
-
Postpartum Depression
NCT05595512 ·Status: COMPLETED
-
Reducing Risk After an Adverse Pregnancy Outcome
NCT01182363 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes
NCT00553917 ·Status: TERMINATED
-
Development and Assessment of a Mobile Phone Based Intervention to Reduce Maternal Depression and Improve Child Health
NCT02526355 ·Status: COMPLETED ·Phase: NA
-
RE104 Safety and Efficacy Study in Postpartum Depression
NCT06342310 ·Status: COMPLETED ·Phase: PHASE2
-
PRogram In Support of Moms (PRISM): A Pilot Study
NCT02935504 ·Status: COMPLETED ·Phase: NA
-
Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression
NCT02285504 ·Status: COMPLETED ·Phase: PHASE2
-
Perinatal Thymic DYsregulation: Characterization of Perinatal Mood Episodes
NCT07008183 ·Status: RECRUITING ·Phase: NA